Glenmark Pharmaceuticals Ltd 2024 SR
The report highlights Glenmark Pharmaceuticals Limited's environmental, social, and governance performance for the fiscal year 2024. Key achievements include launching all 16 global safety programs, impacting 3.3 million lives, and maintaining 33% female representation on the Board of Directors. On the environmental front, the company reported Scope 1 emissions of 15,455 tCO2e and Scope 2 emissions of 69,632 tCO2e, while working toward its target of becoming carbon neutral by 2030. Additionally, Glenmark has achieved zero waste to landfill at five manufacturing sites and one R&D center, progressing toward its 2027 goal.
Company: Glenmark Pharmaceuticals Ltd
Sector: Health Care
Country: India
Year: 2024
Type: SR
Pages: 25
Glenmark Pharmaceuticals Ltd
CSR Impact Assessment Summary Report
The report highlights Glenmark Pharmaceuticals Limited's environmental, social, and governance performance for the fiscal year 2024. Key achievements include launching all 16 global safety programs, impacting 3.3 million lives, and maintaining 33% female representation on the Board of Directors. On the environmental front, the company reported Scope 1 emissions of 15,455 tCO2e and Scope 2 emissions of 69,632 tCO2e, while working toward its target of becoming carbon neutral by 2030. Additionally, Glenmark has achieved zero waste to landfill at five manufacturing sites and one R&D center, progressing toward its 2027 goal.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Published
Oct 9, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees